These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 26576740)
1. I Believe I Can Fly!: Use of Drosophila as a Model Organism in Neuropsychopharmacology Research. Narayanan AS; Rothenfluh A Neuropsychopharmacology; 2016 May; 41(6):1439-46. PubMed ID: 26576740 [TBL] [Abstract][Full Text] [Related]
2. Using Drosophila as a tool to identify pharmacological therapies for fragile X syndrome. McBride SM; Holloway SL; Jongens TA Drug Discov Today Technol; 2013; 10(1):e129-36. PubMed ID: 24050241 [TBL] [Abstract][Full Text] [Related]
4. Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials. Braat S; Kooy RF Neuropharmacology; 2015 Jan; 88():48-54. PubMed ID: 25016041 [TBL] [Abstract][Full Text] [Related]
5. ASD, ADHD, mental health conditions and psychopharmacology in neurogenetic syndromes: parent survey. Reilly C; Senior J; Murtagh L J Intellect Disabil Res; 2015 Apr; 59(4):307-18. PubMed ID: 24965264 [TBL] [Abstract][Full Text] [Related]
6. Drosophila strategies to study psychiatric disorders. van Alphen B; van Swinderen B Brain Res Bull; 2013 Mar; 92():1-11. PubMed ID: 21978945 [TBL] [Abstract][Full Text] [Related]
7. Drosophila melanogaster neurobiology, neuropharmacology, and how the fly can inform central nervous system drug discovery. Nichols CD Pharmacol Ther; 2006 Dec; 112(3):677-700. PubMed ID: 16935347 [TBL] [Abstract][Full Text] [Related]
8. Demise of the flies: why Drosophila models still matter. Bakhoum MF; Jackson GR Prog Mol Biol Transl Sci; 2011; 100():483-98. PubMed ID: 21377634 [TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis. De Rubeis S; Fernández E; Buzzi A; Di Marino D; Bagni C Adv Exp Med Biol; 2012; 970():517-51. PubMed ID: 22351071 [TBL] [Abstract][Full Text] [Related]
10. European College of Neuropsychopharmacology (ECNP) - 23rd Congress. Finn DP IDrugs; 2010 Nov; 13(11):753-5. PubMed ID: 21046518 [TBL] [Abstract][Full Text] [Related]
11. RNA interference: a new mechanism by which FMRP acts in the normal brain? What can Drosophila teach us? Siomi H; Ishizuka A; Siomi MC Ment Retard Dev Disabil Res Rev; 2004; 10(1):68-74. PubMed ID: 14994291 [TBL] [Abstract][Full Text] [Related]
12. Techniques: fruit flies as models for neuropharmacological research. Manev H; Dimitrijevic N; Dzitoyeva S Trends Pharmacol Sci; 2003 Jan; 24(1):41-3. PubMed ID: 12498730 [TBL] [Abstract][Full Text] [Related]
13. Come FLY with us: toward understanding fragile X syndrome. Zarnescu DC; Shan G; Warren ST; Jin P Genes Brain Behav; 2005 Aug; 4(6):385-92. PubMed ID: 16098136 [TBL] [Abstract][Full Text] [Related]
14. Deciphering discord: How Drosophila research has enhanced our understanding of the importance of FMRP in different spatial and temporal contexts. Weisz ED; Monyak RE; Jongens TA Exp Neurol; 2015 Dec; 274(Pt A):14-24. PubMed ID: 26026973 [TBL] [Abstract][Full Text] [Related]
15. Mental retardation genes in drosophila: New approaches to understanding and treating developmental brain disorders. Restifo LL Ment Retard Dev Disabil Res Rev; 2005; 11(4):286-94. PubMed ID: 16240406 [TBL] [Abstract][Full Text] [Related]
16. An in vivo technique for pharmacological manipulation of Drosophila brain during optical recording. Wright NJ J Neurosci Methods; 2006 Jul; 155(1):77-80. PubMed ID: 16497386 [TBL] [Abstract][Full Text] [Related]
17. [Application and prospect of model organism Drosophila melanogaster in activity evaluating and efficacy characterization of traditional Chinese medicine]. Hua YQ; Zhu Y; Jiang F; Yu CY; Ding Y; Duan JA Zhongguo Zhong Yao Za Zhi; 2016 Sep; 41(18):3307-3313. PubMed ID: 28925110 [TBL] [Abstract][Full Text] [Related]
18. Etiology of Human Genetic Disease on the Fly. Chow CY; Reiter LT Trends Genet; 2017 Jun; 33(6):391-398. PubMed ID: 28420493 [TBL] [Abstract][Full Text] [Related]
19. Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome. Berry-Kravis E Pediatr Neurol; 2014 Apr; 50(4):297-302. PubMed ID: 24518745 [TBL] [Abstract][Full Text] [Related]
20. Why flies? Inexpensive public engagement exercises to explain the value of basic biomedical research on Drosophila melanogaster. Pulver SR; Cognigni P; Denholm B; Fabre C; Gu WX; Linneweber G; Prieto-Godino L; Urbancic V; Zwart M; Miguel-Aliaga I Adv Physiol Educ; 2011 Dec; 35(4):384-92. PubMed ID: 22139775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]